spine-education.org

SYNTHES RECEIVES FDA-APPROVAL FOR PRODISC-C

Synopsis:  The Spine Education and Research Institute is pleased to announce that the US FDA (Food and Drug Administration) has fully approved Synthes ProDisc-C Total Disc Replacement for commercial sale and distribution in the United States.  At the Spine Education and Research Institute, Dr. Michael Janssen is an innovator in the breakthrough treatment of disc arthroplasty; a non-fusion technology with as much significant impact to spine treatment as internal fixation influenced modern fracture cases.  Dr. Janssen serves as Principle Investigator for human clinical trials of the recently FDA approved Synthes ProDisc-L.  He also has the highest enrollment of ProDisc-C study patients in the US with extensive experience comparing artificial disc replacement to circumferential fusion.  His research evaluates pain and disability, neurological status, and the maintenance or improvement of flexion-extension/range of motion.  With continued interest in advancing non-fusion technologies and education, Dr. Janssen will be involved with the training of over 1,000 US surgeons in the upcoming months.

Contact: Ruth Beckham, Clinical Research Nurse, at 720.540.7374 or This e-mail address is being protected from spam bots, you need JavaScript enabled to view it .
Download press release here.